Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Camizestrant TFA (AZD-9833 TFA) is a potent and orally active antagonist of estrogen receptor (ER).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 173.00 | |
5 mg | In stock | $ 427.00 | |
10 mg | In stock | $ 632.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,350.00 | |
100 mg | In stock | $ 1,830.00 | |
500 mg | In stock | $ 3,660.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 448.00 |
Description | Camizestrant TFA (AZD-9833 TFA) is a potent and orally active antagonist of estrogen receptor (ER). |
In vivo | Camizestrant TFA (oral administration; 0.2-50 mg/kg; 20 days) shows anti-tumour efficacy in human parental MCF7 mice xenograft. Camizestrant TFA (oral administration; 0.8-40 mg/kg; 30 days) decreases tumor growth. Camizestrant TFA gives almost complete tumour growth inhibition at the doses >10 mg/kg in mice[1]. |
Synonyms | Camizestrant TFA(2222844-89-3 Free base), AZD-9833 TFA |
Molecular Weight | 590.54 |
Formula | C26H29F7N6O2 |
CAS No. | T11237L |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 70 mg/mL (118.54 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Camizestrant TFA T11237L Endocrinology/Hormones Estrogen Receptor/ERR Camizestrant TFA(2222844-89-3 Free base) AZD-9833 TFA inhibitor inhibit